RxDoctor Payments Data

Anjana Pillai, MD

Gastroenterology · Cleveland, OHNPI 1154591428

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 36.1% of the total. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,362in general payments, 2019–2025

Across 81 payments — averaging $1424.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$42K
  • Eisai Inc.$28K
  • Genentech, Inc.$15K
  • AstraZeneca$10K
  • Genentech USA, Inc.$6K
  • Fujifilm Healthcare Americas Corporation$5K
  • plus $9K from 8 others
$85,828in research payments, 2019–2025

Across 17 payments — averaging $5048.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$86K

What the payments were for

  • Consulting fees$53,17846%
  • Speaking & faculty fees$53,99747%
  • Travel & lodging$5,1624%
  • Food & beverage$3,0093%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,362 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$36,785
Medicare patients
165
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VeltassaPatiromer Calcium Sorbitex18$56,588
Tacrolimus94$14,511
OzempicSemaglutide12$11,433
Ursodiol24$7,377
Entecavir38$7,377
Mycophenolate Mofetil15$474
Omeprazole11$290
Spironolactone15$255
Furosemide40$244
Carvedilol34$157
Azathioprine12$145
Pantoprazole Sodium22$139
Amlodipine Besylate20$77

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →